Compare BLTE & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLTE | FMC |
|---|---|---|
| Founded | 2018 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.6B |
| IPO Year | 2022 | N/A |
| Metric | BLTE | FMC |
|---|---|---|
| Price | $142.01 | $13.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 13 |
| Target Price | ★ $149.00 | $25.58 |
| AVG Volume (30 Days) | 290.7K | ★ 4.6M |
| Earning Date | 11-10-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 16.68% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,608,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $49.00 | $12.17 |
| 52 Week High | $161.32 | $57.00 |
| Indicator | BLTE | FMC |
|---|---|---|
| Relative Strength Index (RSI) | 58.92 | 31.81 |
| Support Level | $141.00 | $12.81 |
| Resistance Level | $161.32 | $14.29 |
| Average True Range (ATR) | 11.23 | 0.60 |
| MACD | -1.58 | 0.54 |
| Stochastic Oscillator | 57.94 | 17.52 |
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.